South Korea · Delayed Price · Currency is KRW Hanall Biopharma Statistics
Total Valuation
KRX:009420 has a market cap or net worth of KRW 3.28 trillion. The enterprise value is 3.30 trillion.
| Market Cap | 3.28T |
| Enterprise Value | 3.30T |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:009420 has 50.79 million shares outstanding. The number of shares has increased by 3.84% in one year.
| Current Share Class | 50.79M |
| Shares Outstanding | 50.79M |
| Shares Change (YoY) | +3.84% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 0.44% |
| Owned by Institutions (%) | 15.25% |
| Float | 34.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.17 |
| PB Ratio | 20.30 |
| P/TBV Ratio | 31.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.49 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 6.18 |
| Debt / FCF | -4.16 |
| Interest Coverage | 4.40 |
Financial Efficiency
Return on equity (ROE) is -15.68% and return on invested capital (ROIC) is 2.26%.
| Return on Equity (ROE) | -15.68% |
| Return on Assets (ROA) | 1.14% |
| Return on Invested Capital (ROIC) | 2.26% |
| Return on Capital Employed (ROCE) | 2.20% |
| Weighted Average Cost of Capital (WACC) | 8.97% |
| Revenue Per Employee | 535.06M |
| Profits Per Employee | -81.92M |
| Employee Count | 304 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 1.95 |
Taxes
| Income Tax | -2.84B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +112.85% in the last 52 weeks. The beta is 0.88, so KRX:009420's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +112.85% |
| 50-Day Moving Average | 55,053.00 |
| 200-Day Moving Average | 51,571.25 |
| Relative Strength Index (RSI) | 62.67 |
| Average Volume (20 Days) | 344,185 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:009420 had revenue of KRW 162.66 billion and -24.90 billion in losses. Loss per share was -481.41.
| Revenue | 162.66B |
| Gross Profit | 85.74B |
| Operating Income | 3.92B |
| Pretax Income | -27.75B |
| Net Income | -24.90B |
| EBITDA | 7.28B |
| EBIT | 3.92B |
| Loss Per Share | -481.41 |
Balance Sheet
The company has 30.20 billion in cash and 44.99 billion in debt, with a net cash position of -14.80 billion or -291.36 per share.
| Cash & Cash Equivalents | 30.20B |
| Total Debt | 44.99B |
| Net Cash | -14.80B |
| Net Cash Per Share | -291.36 |
| Equity (Book Value) | 161.63B |
| Book Value Per Share | 3,177.29 |
| Working Capital | 30.72B |
Cash Flow
In the last 12 months, operating cash flow was -9.54 billion and capital expenditures -1.27 billion, giving a free cash flow of -10.81 billion.
| Operating Cash Flow | -9.54B |
| Capital Expenditures | -1.27B |
| Depreciation & Amortization | 3.36B |
| Net Borrowing | 42.96B |
| Free Cash Flow | -10.81B |
| FCF Per Share | -212.80 |
Margins
Gross margin is 52.71%, with operating and profit margins of 2.41% and -15.31%.
| Gross Margin | 52.71% |
| Operating Margin | 2.41% |
| Pretax Margin | -17.06% |
| Profit Margin | -15.31% |
| EBITDA Margin | 4.48% |
| EBIT Margin | 2.41% |
| FCF Margin | n/a |
Dividends & Yields
KRX:009420 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.84% |
| Shareholder Yield | -3.84% |
| Earnings Yield | -0.76% |
| FCF Yield | -0.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for KRX:009420 is 93,666.67, which is 45.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 93,666.67 |
| Price Target Difference | 45.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 12.86% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on April 28, 2006. It was a forward split with a ratio of 10.
| Last Split Date | Apr 28, 2006 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
KRX:009420 has an Altman Z-Score of 17.8 and a Piotroski F-Score of 3.
| Altman Z-Score | 17.8 |
| Piotroski F-Score | 3 |